Source: Biomedicine & Pharmacotherapy. Unidade: ICB
Subjects: ANATOMIA, ANTIOXIDANTES, MIOCÁRDIO, FLAVONOIDES, MODELOS ANIMAIS DE DOENÇAS, RATOS WISTAR, COLÁGENO, DIABETES MELLITUS, FIBROBLASTOS, GLUTAMINA, ESTRESSE OXIDATIVO, SUPERÓXIDO DISMUTASE
ABNT
PURIFICAÇÃO, Natan Reyges Castro da et al. Combined use of systemic quercetin, glutamine and alpha-tocopherol attenuates myocardial fibrosis in diabetic rats. Biomedicine & Pharmacotherapy, v. 151, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2022.113131. Acesso em: 25 ago. 2024.APA
Purificação, N. R. C. da, Garcia, V. B., Frez, F. C. V., Sierakowski, C. C. S., Lima, K. R. D. A., Lima, M. F. de O., et al. (2022). Combined use of systemic quercetin, glutamine and alpha-tocopherol attenuates myocardial fibrosis in diabetic rats. Biomedicine & Pharmacotherapy, 151, 1-12. doi:10.1016/j.biopha.2022.113131NLM
Purificação NRC da, Garcia VB, Frez FCV, Sierakowski CCS, Lima KRDA, Lima MF de O, Vasconcelos R de C, Araujo AA de, Araújo Júnior RF de, Lacchini S. Combined use of systemic quercetin, glutamine and alpha-tocopherol attenuates myocardial fibrosis in diabetic rats [Internet]. Biomedicine & Pharmacotherapy. 2022 ; 151 1-12.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.biopha.2022.113131Vancouver
Purificação NRC da, Garcia VB, Frez FCV, Sierakowski CCS, Lima KRDA, Lima MF de O, Vasconcelos R de C, Araujo AA de, Araújo Júnior RF de, Lacchini S. Combined use of systemic quercetin, glutamine and alpha-tocopherol attenuates myocardial fibrosis in diabetic rats [Internet]. Biomedicine & Pharmacotherapy. 2022 ; 151 1-12.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.biopha.2022.113131